Upgrade to SI Premium - Free Trial

MLV & Co. Downgrades Acadia Pharmaceuticals (ACAD) to Hold

August 7, 2013 7:50 AM
MLV & Co. downgraded Acadia Pharmaceuticals (NASDAQ: ACAD) from Buy to Hold ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Downgrades

Next Articles